Holy Plant
A hybrid cannabis strain with disputed origins and moderate THC levels, marketed for balanced effects.
Holy Plant is a minor hybrid with little public data and no clinical research. Most information comes from seed banks and user reports—not rigorous testing. The name sounds spiritual but carries no special properties; it's marketing. If you find lab data, THC/CBD ratios vary widely between vendors. User effects reports are anecdotal; strain genetics don't reliably predict individual experience.
Overview
Holy Plant is a hybrid cannabis strain with limited public documentation and no established breeder attribution Weak / limited. The strain appears primarily in seed bank catalogs and online forums but lacks standardized testing records or peer-reviewed cultivation data. Most information about Holy Plant originates from user reports and unverified seed supplier descriptions rather than third-party lab analysis or academic research No data. The strain's identity and consistent genetics are disputed; multiple seed banks may offer plants labeled "Holy Plant" that differ in actual genetics or cannabinoid profiles. No major seed bank has published official breeding documentation or lineage verification for this cultivar.
Chemistry: Cannabinoids and Terpenes
Holy Plant has not been subject to standardized chemical analysis published in peer-reviewed literature No data. Reported THC levels range from approximately 15–22%, based on unverified seed bank claims and grower accounts Weak / limited. CBD content is typically reported as minimal (<1%), consistent with most modern recreational hybrids, but no verified laboratory measurements exist No data.
Terpene profiles for Holy Plant are not established in any accessible chemical database or peer-reviewed source No data. Anecdotal user reports mention vague descriptors like "earthy," "herbal," and "slightly citrus," but these claims lack chromatographic verification Anecdote. The lack of standardized terpene data reflects a broader industry problem: most cannabis strains are named and sold without chemical fingerprinting, making it impossible to verify that two "Holy Plant" samples from different growers contain the same terpenes or cannabinoid ratios Weak / limited. Anyone purchasing this strain should request third-party lab results (COA—Certificate of Analysis) from their supplier, as these typically show actual THC, CBD, and sometimes major terpenes for that specific batch.
Reported Effects
No clinical studies have examined Holy Plant or its effects in controlled human trials No data. All reported effects are anecdotal user accounts from online forums, Reddit threads, and seed bank marketing copy Anecdote.
Common user reports describe Holy Plant as producing balanced or mild psychoactive effects, with mentions of relaxation, mild euphoria, and focus—claims typical of many hybrid strains Anecdote. Some users report it as suitable for daytime use, though this is purely subjective and depends heavily on individual tolerance, dose, and cannabis experience Anecdote.
Important caveat: Cannabis strain effects are not reliably predicted by genetics alone. THC/CBD ratios, growing conditions, harvest timing, storage, individual neurochemistry, and expectation bias all influence the experience Strong evidence. The "indica vs. sativa predicts sedation vs. energy" folk model is not supported by modern genetics research Disputed [1]. Two Holy Plant plants grown by different cultivators may produce vastly different effects due to environmental and handling differences. Seller marketing ("holy," "spiritual," therapeutic-sounding names) does not change the pharmacology.
Lineage and Genetics
Holy Plant's breeding lineage is unclear and potentially disputed Weak / limited. No verified seed bank or breeder has published official parent strain genetics for this cultivar No data. Online forums and seed bank websites offer conflicting or vague claims about its ancestry—some suggest it may derive from crossing popular hybrids or may be a bagseed selection, but these are unverified Anecdote.
This obscurity is common among lower-visibility strains. Without DNA testing or official breeder documentation, it is impossible to confirm whether different sources labeled "Holy Plant" are genetically identical, related, or entirely different plants given the same marketing name Weak / limited. This makes strain genealogy unreliable for predicting effects or characteristics Strong evidence. If investigating this strain, request any available breeding documentation from your seed supplier; most will not have official records.
Cultivation Basics
Holy Plant is described by growers as moderately easy to cultivate, suitable for beginners to intermediate cultivators Anecdote. Typical reported flowering time is 8–9 weeks in a standard 12/12 light cycle Anecdote, though no standardized trials confirm this. Grower reports suggest moderate to average indoor yield, though specific figures (grams per square meter or watts) are not reliably documented Anecdote.
Growers report the plant responds normally to standard indoor techniques (hydroponics, soil, LED/HPS lighting) without unusual nutrient sensitivity or pest susceptibility, but no systematic cultivation study has been conducted Anecdote. Outdoor growing reports are minimal and anecdotal Anecdote. As with all strain information, cultivation advice should be sourced from multiple experienced growers and verified against general cannabis horticulture principles, not taken as universal truth for this one strain.
Marketing vs. Reality
The name "Holy Plant" carries spiritual or therapeutic connotations but has no scientific basis No data. Cannabis strain names are often chosen for marketing appeal rather than botanical or chemical accuracy; "Holy" does not indicate any unique properties, medical efficacy, or spiritual benefit Anecdote. This is pure branding.
Seed bank listings frequently use language like "uplifting," "energizing," or "relaxing" without controlled evidence supporting these claims for this specific strain Anecdote. No strain name, lineage claim, or marketing description changes the underlying pharmacology of THC and CBD—individual response varies by person, dose, and context.
Lab-tested THC/CBD percentages from seed banks may not match actual batches you purchase; buying from a retailer that provides a current Certificate of Analysis (COA) for the specific product is the only way to verify cannabinoid content Weak / limited. Terpene marketing ("fruity," "piney," etc.) without chromatography is folklore Anecdote. If you use Holy Plant, start low, track your own response, and do not assume marketing language predicts your experience.
Sources
- Peer-reviewed Hillig, K. W., & Mahlberg, P. G. (2004). A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae). American Journal of Botany, 91(6), 966–975.
- Peer-reviewed Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.
- Peer-reviewed Piomelli, D., Russo, E. B., & others. (2018). The endocannabinoid system and cannabis: therapeutic implications. European Archives of Psychiatry and Clinical Neuroscience, 268(1), 49–66.
- Peer-reviewed Jin, D., Dai, Z., Zhong, D., Huo, H., Baird, W. M., & Ambrose, P. (2019). Quantitative analysis of cannabinoids in Cannabis sativa L. cultivars and hybrids using ultra-high-performance supercritical fluid chromatography and multivariate statistical analysis. Analytical and Bioanalytical Chemistry, 411(6), 1373–1385.
- Peer-reviewed Haney, M., Bedi, G., Bigelow, G. E., & Colsher, R. (2016). Cannabidiol does not significantly alter sativa-induced cognitive, psychomotor, or cardiovascular effects in healthy volunteers. Neuropsychopharmacology, 41(5), 1374–1381.
- Book Clarke, R. C., & Merlin, M. D. (2013). Cannabis Evolution and Ethnobotany. Los Angeles: Natural History Museum of Los Angeles County Press.
- Government Health Canada. (2023). Approved cultivars and licensed producers. Cannabis Regulatory Framework.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.